From: Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
 | SS ≤ 22 (n = 73) | SS > 22 (n = 34) | P value |
---|---|---|---|
Male (%) | 49 (67.1) | 23 (67.6) | 0.957 |
Age (years) | 69.2 (10.97) | 69.7 (9.57) | 0.835 |
BMI (kg/m2) | 24.2 (3.58) | 24.4 (3.50) | 0.696 |
Alcohol users (%) | 8 (11.0) | 6 (17.6) | 0.339 |
Cigarette smoking (%) | 7 (9.6) | 5 (14.7) | 0.435 |
Hypertension (%) | 58 (79.5) | 32 (94.1) | 0.053 |
WBC (109/L) | 5.95 (1.46) | 5.89 (1.36) | 0.857 |
Neutrophil (%) | 62.54 (9.04) | 65.25 (10.39) | 0.171 |
BUN (mmol/L) | 12.04 (6.69) | 13.36 (8.59) | 0.388 |
CRE (μmol/L) | 247.52 (283.44) | 282.74 (249.18) | 0.536 |
UA (μmol/L) | 438.26 (107.56) | 436.59 (91.93) | 0.938 |
CysC (mg/L) | 2.45 (1.97) | 2.98 (1.95) | 0.201 |
eGFR (mL/min/1.73 m2) | 36.9 (16.93) | 30.6 (19.26) | 0.091 |
TC (mmol/L) | 4.07 (1.26) | 3.91 (1.01) | 0.498 |
TG (mmol/L) | 1.70 (1.67) | 1.41 (0.58) | 0.339 |
HDL-C (mmol/L) | 1.08 (0.28) | 1.04 (0.23) | 0.515 |
LDL-C (mmol/L) | 2.41 (0.92) | 2.37 (0.92) | 0.848 |
hsCRP (mg/L) | 5.53 (12.31) | 10.22 (19.69) | 0.139 |
Plasma O-sulfotyrosine (ng/mL) | 294.5 (228.41) | 453.3 (221.38) | 0.001 |
Sulfate (mmol/L) | 1.87 (0.79) | 2.40 (0.80) | 0.002 |